Cite
METABOLOMIC PROFILING SHOWS MORE LIPID ABNORMALITIES IN NNRTI COMPARED TO InSTI USERS.
MLA
Vos, Wilhelm A. J. W., et al. “METABOLOMIC PROFILING SHOWS MORE LIPID ABNORMALITIES IN NNRTI COMPARED TO InSTI USERS.” Topics in Antiviral Medicine, vol. 31, no. 2, Apr. 2023, pp. 266–67. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=163303920&authtype=sso&custid=ns315887.
APA
Vos, W. A. J. W., Vadaq, N., Groenendijk, A. L., Blaauw, M. J. T., van Eekeren, L. E., Matzaraki, V., Brinkman, K., De Mast, Q., van Der Kolk, M., van Lunzen, J., Stalenhoef, J. E., Blok, W. L., & van Der Ven, A. J. A. M. (2023). METABOLOMIC PROFILING SHOWS MORE LIPID ABNORMALITIES IN NNRTI COMPARED TO InSTI USERS. Topics in Antiviral Medicine, 31(2), 266–267.
Chicago
Vos, Wilhelm A. J. W., Nadira Vadaq, Albert L. Groenendijk, Marc J. T. Blaauw, Louise E. van Eekeren, Vasiliki Matzaraki, Kees Brinkman, et al. 2023. “METABOLOMIC PROFILING SHOWS MORE LIPID ABNORMALITIES IN NNRTI COMPARED TO InSTI USERS.” Topics in Antiviral Medicine 31 (2): 266–67. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=163303920&authtype=sso&custid=ns315887.